Deadline for abstract submission extended to November 27 ! Submit an abstract: here We are pleased to invite you to... View Article
Author Archives for Adeline Chauvigné
[CALL for ABSTRACTS] 4th Nuclear Technologies for Health Symposium- NTHS 2020 | Nantes February 13-14, 2020
30 June 2025Deadline for abstract submission extended to November 27 ! Submit an abstract: here We are pleased to invite you to... View Article
OSE Immunotherapeutics Presented Positive Correlation Between Neoepitope Response and Increased Survival for NSCLC Patients Treated with Tedopi®
OSE Immunotherapeutics, member of Atlanpole Biotherapies, announce that new clinical and preclinical data on its products in immuno-oncology-Tedopi®,BI 765063 (OSE-172)... View Article
OSE Immunotherapeutics Presented Positive Correlation Between Neoepitope Response and Increased Survival for NSCLC Patients Treated with Tedopi®
30 June 2025OSE Immunotherapeutics, member of Atlanpole Biotherapies, announce that new clinical and preclinical data on its products in immuno-oncology-Tedopi®,BI 765063 (OSE-172)... View Article
Porsolt increases its drug discovery service capabilities with the recent expansion of its research facility
Laval, France, 3rd September 2019 – Porsolt SAS, a long established preclinical screening, efficacy, and safety CRO, has completed a... View Article
Porsolt increases its drug discovery service capabilities with the recent expansion of its research facility
30 June 2025Laval, France, 3rd September 2019 – Porsolt SAS, a long established preclinical screening, efficacy, and safety CRO, has completed a... View Article
InFlectis BioScience announces favorable results for IFB-088 Phase 1 Single Ascending Dose clinical trial
IFB-088 observed to have a favorable safety, tolerability and pharmacokinetic profile in the Phase 1 trial IFB-088 is advancing into... View Article
InFlectis BioScience announces favorable results for IFB-088 Phase 1 Single Ascending Dose clinical trial
30 June 2025IFB-088 observed to have a favorable safety, tolerability and pharmacokinetic profile in the Phase 1 trial IFB-088 is advancing into... View Article
In-Cell-Art announces the publication in Nature Biomedical Engineering of a Nanotaxi® for messenger RNA vaccin
In-Cell-Art (ICA), a biotechnology company specialized in nanocarrier technologies named Nanotaxi® for unlocking the promise of nucleic acids to treat... View Article
In-Cell-Art announces the publication in Nature Biomedical Engineering of a Nanotaxi® for messenger RNA vaccin
30 June 2025In-Cell-Art (ICA), a biotechnology company specialized in nanocarrier technologies named Nanotaxi® for unlocking the promise of nucleic acids to treat... View Article
Premium ADCC project, positive results for Clean Cells
An example of an innovative product placed on the market thanks to a collaborative innovation project financed by the Single... View Article
Premium ADCC project, positive results for Clean Cells
30 June 2025An example of an innovative product placed on the market thanks to a collaborative innovation project financed by the Single... View Article
New member | Hera-MI
Artificial intelligence used for the radiological diagnosis of breast cancer The patented Breast-SlimView solution developed by Hera-MI provides an innovative... View Article
New member | Hera-MI
30 June 2025Artificial intelligence used for the radiological diagnosis of breast cancer The patented Breast-SlimView solution developed by Hera-MI provides an innovative... View Article
New member | Therenva
Therenva SAS, based in Rennes, designs, develops and markets innovative software solutions for planning and navigating endovascular procedures based on... View Article
New member | Therenva
30 June 2025Therenva SAS, based in Rennes, designs, develops and markets innovative software solutions for planning and navigating endovascular procedures based on... View Article
Atlanpole Biotherapies gathered its members together on 28th February for its General Meeting
150 people were in attendance at the cluster’s “assessment and goals” day: 12 new members pitched: Hera-Mi, Biologbook, Bee Healthcare, ARS... View Article
Atlanpole Biotherapies gathered its members together on 28th February for its General Meeting
30 June 2025150 people were in attendance at the cluster’s “assessment and goals” day: 12 new members pitched: Hera-Mi, Biologbook, Bee Healthcare, ARS... View Article
A fantastic edition of the Bioregate Forum 2018 in Nantes
The International Forum for those involved in regenerative medicine took place on 12th-14th December in Nantes. It was attended by... View Article
A fantastic edition of the Bioregate Forum 2018 in Nantes
30 June 2025The International Forum for those involved in regenerative medicine took place on 12th-14th December in Nantes. It was attended by... View Article